EP Patent

EP1695700A1 — Dosage form containing oxycodone and naloxone

Assigned to Euro Celtique SA · Expires 2006-08-30 · 20y expired

What this patent protects

The present invention concerns a dosage form comprising oxycodone and naloxone which characterized by specific in vivo parameters such as t max , C max , AUCt value, mean bowel function score and/or duration of analgesic efficacy.

USPTO Abstract

The present invention concerns a dosage form comprising oxycodone and naloxone which characterized by specific in vivo parameters such as t max , C max , AUCt value, mean bowel function score and/or duration of analgesic efficacy.

Drugs covered by this patent

Patent Metadata

Patent number
EP1695700A1
Jurisdiction
EP
Classification
—
Expires
2006-08-30
Drug substance claim
No
Drug product claim
No
Assignee
Euro Celtique SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.